在T细胞内在的VISTA表达通过限制CD8+T细胞反应,促进对CTLA-4阻断的抵抗
Cassandra Gilmour1, Elizabeth DeLaney1, Prerana B Parthasarathy2
1Department of Translational Hematology & Oncology Research.
The Journal of clinical investigation
|March 16, 2026
概括
从T细胞中删除V域免疫球蛋白抑制T细胞激活 (VISTA) 可以改善对瘤的初始反应,但不能提供持久的控制. 将VISTA阻塞与CTLA-4抑制相结合,可以增强T细胞功能和瘤排斥.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- T细胞生物学T细胞生物学
背景情况:
- 维域免疫球蛋白抑制T细胞激活 (VISTA) 是一种免疫检查点蛋白质,可以负面调节T细胞的反应.
- 对于T细胞内在VISTA在抗瘤免疫中的作用尚未完全理解.
研究的目的:
- 调查删除T细胞特异性VISTA对CD8+T细胞对瘤反应的影响.
- 探索针对VISTA与CTLA-4阻断结合的治疗潜力.
主要方法:
- 单细胞转录基因分析
- 在 TCR 曲目中,编制了 TCR 曲目谱的个人资料.
- 流动细胞计量流动细胞计量
- 在体内瘤模型.
主要成果:
- 特定于T细胞的VISTA删除增强了早期CD8+T细胞的原始化和扩张,但没有导致持久的瘤控制.
- 对髓状细胞的Trans-VISTA和CTLA-4上调有助于T细胞功能障碍.
- 结合VISTA阻塞和CTLA-4抑制改善了T细胞存活率,TCR谱系多样性和瘤回归.
- 与VISTA缺陷相关的转录特征预测了癌症患者的良好结果.
结论:
- 具有T细胞内在性的VISTA在瘤微环境中促进T细胞功能障碍.
- 针对VISTA,特别是与CTLA-4封锁相结合,为增强抗瘤免疫提供了一个有希望的策略.
- 维斯塔可以作为预测免疫检查点抑制剂反应的生物标志物.
相关概念视频
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
T Cell Activation and Clonal Selection
17.0K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
17.0K
T Cell Types and Functions
3.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K
Cytotoxic T Cells-mediated Immune Response
7.8K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K


